Freenome
Pre-clinicalFreenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.
Founded
2014
Focus
Diagnostics
About
Freenome is a private biotech company focused on developing blood tests to detect cancer early and make screening accessible for everyone.
Funding History
4Total raised: $500.5M
Series C$270MBain Capital Life SciencesMar 15, 2021
Series B$160MPerceptive AdvisorsOct 15, 2019
Series A$65MGoogle VenturesAug 15, 2017
Seed$5.5MAndreessen HorowitzJun 15, 2015
Company Info
TypePrivate
Founded2014
LocationSouth San Francisco, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile